课题基金 / 基金详情

Experimental study of the therapeutic effect of synthetic peptide for Sjogren's syndrome

Experimental study of the therapeutic effect of synthetic peptide for Sjogren's syndrome
合成肽治疗干燥综合征的实验研究
批准号:
07557121
负责人:
HAYASHI Yoshio
金额:
$10.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996

项目摘要

项目成果

HAYASHI Yoshio的其他基金

相似基金

相关文献

中文摘要
翻译
人类原发性干燥综合征是一种病因不明的自身免疫性疾病,其特征在于外分泌器官如唾液腺和泪腺中的弥漫性淋巴浸润,但还没有合适的人类疾病动物模型。人们一直认为,免疫,遗传和环境因素的组合可能在唾液腺和泪腺的自身免疫性病变的发展中发挥关键作用,但对原发性干燥综合征的发病机制知之甚少。我们建立了一个原发性干燥综合征的动物模型,在NFS/sld突变小鼠携带一个常染色体隐性基因与舌下分化停滞。在出生后3天切除胸腺的这一品系小鼠中,唾液腺和泪腺自发地发生严重的自身免疫性病变。这种动物模型对于研究和阐明原发性干燥综合征中自身免疫性疾病的发病机制至关重要。最近,我们从NFS/sld动物模型的唾液腺组织中纯化了120 KDa器官特异性自身抗原。这种纯化的抗原诱导增殖性T细胞应答,以及细胞因子产生,包括IL-2和干扰素-γ。静脉注射合成肽预防小鼠器官特异性自身免疫性病变。我们推测抗120 KDa免疫应答在原发性干燥综合征的发生发展中起关键作用。
英文摘要
Primary Sjogren's syndrome in humans is an autoimmune disease of unknown etiology that is characterized by diffuse lymphoid infiltrates in the exocrine organs, such as the salivary and lacrimal glands, but there has not been an appropriate animal model of the human disease. It has been assumed that a combination of immunologic, genetic, and environmental factors may play a key role in development of autoimmune lesions in the salivary and lacrimal glands, but little is known about the disease pathogenesis of primary Sjogren's syndrome. We have established an animal model for primary Sjogren's syndrome in NFS/sld mutant mice bearing an autosomal recessive gene with sublingual differentiation arrest. Severe autoimmune lesions in the salivary and lacrimal glands developed spontaneously in this strain of mice thymectomized 3 day after birth. Such an animal model is essential to study and elucidate the pathogenesis of autoimmune disorders in primary Sjogren's syndrome. More recently, we purified 120KDa organ-specific autoantigen from salivary gland tissues of an NFS/sld animal model. This purified antigen induced proliferative T cell responses, as well as cytokine production including IL-2, and interferon-gamma. Intravenous injection with synthetic peptide prevented the organ-specific autoimmune lesions in mice. We can speculate that the anti-120 KDa immune response play a critical role in the development of primary Sjogren's syndrome.
期刊论文(50)
专著(0)
科研奖励(0)
会议论文
Yoshio Hayashi et al: "Biased T cell receptor Vβ gene usage during dpecific stages of the development of autoimmune sialadenitis in the MRL/lpr mouse model of Sjogren's syndrome" Arthritis Rheum.38(8). 1077-1084 (1995)
Yoshio Hayashi 等人:“干燥综合征 MRL/lpr 小鼠模型中自身免疫唾液腺炎发展的特定阶段中 T 细胞受体 Vβ 基因的使用偏向”Arthritis Rheum.38(8) (1995)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Y.Miyamoto, K.Satomura, K.Rikimaru, Y.Hayashi: "Desmoplastic fibroma of the mandible associated with tuberous sclerosis." J.Oral Pathol. Med.24. 93-96 (1995)
Y.Miyamoto、K.Satomura、K.Rikimaru、Y.Hayashi:“与结节性硬化症相关的下颌骨促纤维增生性纤维瘤。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Mizushima, N., Kohsaka, H., Tsubota, K., Saito, I., Miyasaka, N.: "Diverse T cell receptor beta gene usage by infiltrating T cells in the lacrimal glands of Sjogren's syndrome" Clin.Exp.Immunol. 101. 33-38 (1995)
Mizushima, N.、Kohsaka, H.、Tsubota, K.、Saito, I.、Miyasaka, N.:“通过浸润干燥综合征泪腺中的 T 细胞来使用不同的 T 细胞受体 β 基因” Clin.Exp.Immunol
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Sachiko Iseki, Akihiko Araga, Hideyo Ohuchi, Tsutomu Nono, Hidefumi Yoshioka, Yoshio Hayashi, Sumihare Noji: "Sonic hedgehog is expressed in epithelial cells during development of whiskar, hair, and tooth" Biochem.Biophys.Res.Commun. 218. 688-693 (1996)
Sachiko Iseki、Akihiko Araga、Hideyo Ohuchi、Tsutomu Nono、Hidefumi Yoshioka、Yoshio Hayashi、Sumihare Noji:“Sonic Hedgehog 在须、毛发和牙齿发育过程中在上皮细胞中表达”Biochem.Biophys.Res.Commun。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 43 条
    Study on Medicinal Chemistry of Reversible Cysteine Protease Inhibitors for the Treatment of Infectious Diseases
    • 批准号:
      23659059
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2011
    • 负责人:
      HAYASHI Yoshio
    • 依托单位:
    Integrated medicinal chemistry research of intractable diseases based on peptidic small molecules
    Immunotherapeutic analysis using newly established murine models for Sjogren' s syndrome
    • 批准号:
      21249090
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $29.54万
    • 财政年份:
      2009
    • 负责人:
      HAYASHI Yoshio
    • 依托单位:
    Study on Medicinal Chemistry, Chemical Biology and Chemical Pharmaceutics of Anticancer Drug Based on the Microtubule Targeting Agents
    海外基金